During the past decade, Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" are "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials) and "Lymphocytic Leukemia, Chronic" (1 trials). Many other conditions were trialed in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" in a lesser frequency.

Most popular intervention types in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".